Nexalin Technology, Inc. Other Income
Nexalin Technology, Inc. (NXL) reported Other Income of $2.01 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Other Income
us-gaap:OtherIncome · last filed 2026-08-12
- Nexalin Technology, Inc. other income for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Nexalin Technology, Inc. other income for the quarter ending 2026-03-31 was $2.01K, a 26.09% decline year-over-year.
- Nexalin Technology, Inc. other income for the quarter ending 2025-12-31 was $8.85K, a 204.96% increase year-over-year.
- Nexalin Technology, Inc. other income for the quarter ending 2025-09-30 was $20.26K, a 610.56% increase year-over-year.
- Nexalin Technology, Inc. other income for fiscal 2025 was $34.57K, a 271.30% increase from fiscal 2024.
- Nexalin Technology, Inc. other income for fiscal 2024 was $9.31K, a 96.11% decline from fiscal 2023.
- Nexalin Technology, Inc. other income for fiscal 2023 was $239.54K, a 39.53% increase from fiscal 2022.
- Nexalin Technology, Inc. other income for fiscal 2022 was $171.68K.
| Period end | Other Income 3 month | Other Income 6 month | Other Income 9 month | Other Income 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $2.01K 10-Q · filed 2026-08-12 | $10.86K derived: sum of 3 quarters · filed 2026-08-12 | $31.12K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $2.01K 10-Q · filed 2026-05-08 | $10.86K derived: sum of 2 quarters · filed 2026-05-08 | $31.12K derived: sum of 3 quarters · filed 2026-05-08 | $33.86K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $8.85K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $29.11K derived: sum of 2 quarters · filed 2026-03-25 | $31.85K derived: sum of 3 quarters · filed 2026-08-12 | $34.57K 10-K · filed 2026-03-25 |
| 2025-09-30 | $20.26K 10-Q · filed 2025-11-14 | $23.00K derived: sum of 2 quarters · filed 2026-08-12 | $25.71K 10-Q · filed 2025-11-14 | $28.62K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | $2.74K 10-Q · filed 2026-08-12 | $5.46K 10-Q · filed 2026-08-12 | $8.36K derived: sum of 3 quarters · filed 2026-08-12 | $11.21K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | $2.71K 10-Q · filed 2026-05-08 | $5.62K derived: sum of 2 quarters · filed 2026-05-08 | $8.47K derived: sum of 3 quarters · filed 2026-05-08 | $10.50K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $2.90K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $5.75K derived: sum of 2 quarters · filed 2026-03-25 | $7.79K derived: sum of 3 quarters · filed 2026-03-25 | $9.31K 10-K · filed 2026-03-25 |
| 2024-09-30 | $2.85K 10-Q · filed 2025-11-14 | $4.88K derived: sum of 2 quarters · filed 2025-11-14 | $6.41K 10-Q · filed 2025-11-14 | $203.07K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $2.03K 10-Q · filed 2025-08-06 | $3.56K 10-Q · filed 2025-08-06 | $200.22K derived: sum of 3 quarters · filed 2025-09-23 | $240.96K derived: sum of 4 quarters · filed 2025-09-23 |
| 2024-03-31 | $1.52K 10-Q · filed 2025-05-13 | $198.19K derived: sum of 2 quarters · filed 2025-09-23 | $238.92K derived: sum of 3 quarters · filed 2025-09-23 | $239.99K derived: sum of 4 quarters · filed 2025-09-23 |
| 2023-12-31 | $196.67K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-09-23 | $237.40K derived: sum of 2 quarters · filed 2025-09-23 | $238.47K derived: sum of 3 quarters · filed 2025-09-23 | $239.54K 10-K/A · filed 2025-09-23 |
| 2023-09-30 | $40.73K 10-Q · filed 2024-11-08 | $41.80K derived: sum of 2 quarters · filed 2024-11-08 | $42.88K 10-Q · filed 2024-11-08 | $46.31K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $1.06K 10-Q · filed 2024-08-08 | $2.14K 10-Q · filed 2024-08-08 | $5.58K derived: sum of 3 quarters · filed 2024-08-08 | $173.82K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $1.08K 10-Q · filed 2024-05-10 | $4.51K derived: sum of 2 quarters · filed 2024-05-10 | $172.76K derived: sum of 3 quarters · filed 2024-05-10 | |
| 2022-12-31 | $3.44K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $171.68K derived: sum of 2 quarters · filed 2024-03-27 | $171.68K 10-K · filed 2024-03-27 | |
| 2022-09-30 | $168.25K 10-Q · filed 2023-11-13 | $168.25K 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |